 Primary hypothesis is that the persons with ARMS who are prescribed minocycline and or Omega-3 fatty acids will have reduced transition rates to psychosis over a one year follow up period from baseline compared with Treatment-As-Usual TAU. The transition rates will be lowest in the group receiving minocycline and Omega-3 fatty acids in combination. 